Takashi Nakamura

10PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 06, 2025
Combination therapy of an 211At-labeled RGD peptide and immune checkpoint blockade to enhance antitumor efficacy.

Hiroaki Echigo, Masayuki Munekane, Takeshi Fuchigami

|Dec 04, 2024
Targeting Tumor Endothelial Cells by EGCG Using Specific Liposome Delivery System Inhibits Vascular Inflammation and Thrombosis.

Zi Jia, Nako Maishi, Hideki Takekawa

|Jan 23, 2024
Cancer Immunotherapy with Lipid Nanoparticles Loaded with a Stimulator of Interferon Genes Agonist against Renal Tumor Lung Metastasis.

Takashi Nakamura, Shun Sasaki, Yusuke Sato

|Mar 10, 2022
Novel antiangiogenic therapy targeting biglycan using tumor endothelial cell-specific liposomal siRNA delivery system.

Nako Maishi, Yu Sakurai, Hiroto Hatakeyama

|Jul 03, 2021
STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation.

Takashi Nakamura, Takanori Sato, Rikito Endo

|Mar 05, 2020
Vitamin E Scaffolds of pH-Responsive Lipid Nanoparticles as DNA Vaccines in Cancer and Protozoan Infection.

Mio Maeta, Naoya Miura, Hiroki Tanaka

Pageof 2

Frequent Collaborators

2 joint publications

Hideyoshi Harashima

2 joint publications

Kyoko Hida

1 joint publications

Masatoshi Maeki

1 joint publications

Manabu Tokeshi